GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset…
Good Purpose Investments Engages MCS Market Communication Services for Online Marketing Services
DelphX Closes Non-Brokered Unit Private Placement
Google Rank Tracker Without a Subscription: SpeedyIndex Launches Pay-Per-Check Rank Tracker with API
Frontline Source Group Launches Fractional Executive Division
Eguana Announces Completion of Second and Final Tranche and Closing of Previously Announced Convertible Debenture Financing